Intracavernous injections: Still the gold standard for treatment of erectile dysfunction in elderly men

International Journal of Impotence Research

Volumn 13, Issue 3, 2001, Pages 172-175

  Richter, S ^a,b   Vardi, Y ^a,b   Ringel, A ^a,b   Shalev, M ^a,b   Nissenkorn, I ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cavernous injections; Elderly men; Erectile dysfunction; Therapy

Indexed keywords

PAPAVERINE; PHENTOLAMINE MESYLATE; PROSTAGLANDIN E1; VASOACTIVE AGENT;

ADULT; AGED; CASE CONTROL STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; ERECTILE DYSFUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; PRIORITY JOURNAL; SELF REPORT; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AGING; ALPROSTADIL; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; HUMANS; IMPOTENCE; INJECTIONS; MALE; MIDDLE AGED; PAPAVERINE; PENILE ERECTION; PENIS; PHENTOLAMINE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0034951217     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900672     Document Type: Article

References (21)

1. Impotence and aging: Clinical and hormonal factors
2. Indications and early results of sildenafil (Viagra) in erectile dysfunction
3. Penile sensitivity, age, and sexual behavior
4. Impotence and its medical and psychosocial correlates: Results of the Massachusets Male Aging Study
5. Non-hormonal pharmacological treatment of impotence
6. The effectiveness of yohimbine in the treatment of impotence: Results of a controlled trial
7. Single cell activity in the noradrenargic A5 region: Responses to drugs and peripheral manipulation of blood pressure
8. Pharmacotherapy for sexual dysfunction: What does the future hold?
9. Oral phentolamine as treatment for erectile dysfunction
10. Erectile response to transurethral alprostadil, prazosin and alprostadil-prazosin combinations
11. Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence
12. The lowest effective dose of prostaglandin E1 as treatment for erectile dysfunction
13. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: A clinical double-blind study
14. Experience with triple drug therapy in a pharmacological erection program
15. Transforming growth factor-beta in disease: The dark side of tissue repair
16. The impact of aging on penile hemodynamics in normal responders to pharmacological injection: A doppler sonographic study
17. Pharmacologically induced erections among geriatric men
18. Cavernous injection therapy for the treatment of erectile dysfunction in elderly men
19. Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction